Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AGIO Agios Pharmaceuticals

Market Closed 10-09 16:00:00 EDT

31.81

-0.11

-0.34%

盘后31.81

+0.000.00%

19:31 EDT

High32.15	Low31.52	Vol835.68K
Open31.85	D1 Closing31.92	Amplitude1.97%
Mkt Cap1.89B	Tradable Cap1.59B	Total Shares59.47M
T/O26.62M	T/O Rate1.67%	Tradable Shares50.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals","latestPrice":31.81,"timestamp":1791576000000,"preClose":31.92,"halted":0,"volume":835681,"hourTrading":{"tag":"盘后","latestPrice":31.81,"preClose":31.81,"latestTime":"19:31 EDT","volume":176074,"amount":5600913.45,"timestamp":1791588702507,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.003446115288220645,"floatShares":50088500,"shares":59471609,"eps":-7.007511,"marketStatus":"Market Closed","change":-0.11,"latestTime":"10-09 16:00:00 EDT","open":31.85,"high":32.15,"low":31.52,"amount":26619292.029253,"amplitude":0.019737,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.007511,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1374638400000,"exchange":"NASDAQ","adjPreClose":31.92,"preHourTrading":{"tag":"盘前","latestPrice":31.81,"preClose":31.92,"latestTime":"09:29 EDT","volume":470,"amount":14964.05975,"timestamp":1791552599999,"change":-0.11,"changeRate":-0.003446,"amplitude":0.02557},"postHourTrading":{"tag":"盘后","latestPrice":31.81,"preClose":31.81,"latestTime":"19:31 EDT","volume":176074,"amount":5600913.45,"timestamp":1791588702507,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6519832771803807,"impliedVol":0.8253,"impliedVolPercentile":0.8606},"requestUrl":"/m/hq/s/AGIO/wiki","defaultTab":"wiki","newsList":[{"id":"2674888234","title":"Agios Pharma (AGIO) Gets a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888234?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:47","pubTimestamp":1791510452,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Hold rating on Agios Pharma yesterday and set a price target of $32.00. According to TipRanks, Issi is a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/agios-pharma-agio-gets-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/agios-pharma-agio-gets-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","BK4139","LU0029864427.USD","GSIB","LU0128525929.USD","LU1267930573.SGD","AGIO","BK4207","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673019974","title":"Agios Pharmaceuticals Price Target Cut to $37.00/Share from $39.00 by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2673019974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673019974?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:14","pubTimestamp":1791386040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013709","title":"Agios Pharmaceuticals price target lowered to $37 from $39 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013709?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:07","pubTimestamp":1791378451,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $37 from $39 and keeps a Buy rating on the shares as part of a broader re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-37-from-39-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-37-from-39-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669632901","title":"BofA Securities Adjusts Agios Pharmaceuticals Price Target to $50 From $46, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2669632901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669632901?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:19","pubTimestamp":1789993149,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals (AGIO) has an average rating of overweight and mean price target of $42.62, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669509461","title":"Agios Pharmaceuticals price target raised to $50 from $46 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2669509461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669509461?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:40","pubTimestamp":1789987225,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Agios Pharmaceuticals (AGIO) to $50 from $46 and keeps a Buy rating on the shares. Despite falling off all-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-raised-to-50-from-46-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-raised-to-50-from-46-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660587452","title":"Agios Pharmaceuticals (AGIO) Could Be 24% Undervalued On PYRUKYND Growth Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2660587452","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660587452?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:22","pubTimestamp":1787030537,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals (AGIO) has drawn investor focus after recent trading left the stock at a last close of $33.63. With mixed return figures across different periods, the company’s rare disease portfolio is gaining fresh attention.\nSee our latest analysis for Agios Pharmaceuticals.\nOver the past year, Agios Pharmaceuticals has combined a 23.73% year to date share price return with a 21.28% 90 day share price gain, yet the 1 year total shareholder return declined 10.20%. This suggests that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-could-be-24-undervalued-on-pyruky","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-could-be-24-undervalued-on-pyruky","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913504","title":"Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913504?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:00","pubTimestamp":1786453226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0157215616.USD","IDNA","LU2756315318.SGD","VRTX","PPA","TRUI","EXI","IE0002270589.USD","GE","MISL","AGIO","VERX","LU0058720904.USD","LU0417517546.SGD","LU0353189680.USD","BK4139","IE00B19Z9P08.USD","ITA","IE0009355771.USD","GNMX","BBH","NATO","IBBQ","UXI","LU0320765992.SGD","PBE","LU0757428866.USD","LU1559883803.SGD","BIB","LGHT","GEHC","LU1093756325.SGD","LU2417539215.USD","LU2756315664.SGD","LU0820561909.HKD","LU1084165304.USD","SG9999001176.SGD","XAR","XLV","BK4588","DFEN","LU1261432733.SGD","METV","BK4532","LABU","LU2089984988.USD","IBB","TBXU","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658675029","title":"Agios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds","url":"https://stock-news.laohu8.com/highlight/detail?id=2658675029","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658675029?lang=en_us&edition=fundamental","pubTime":"2026-08-09 04:19","pubTimestamp":1786220398,"startTime":"0","endTime":"0","summary":"Earnings event puts Agios Pharmaceuticals stock in focus\nAgios Pharmaceuticals (AGIO) reported second quarter 2026 results on July 30, with revenue of US$44.75 million and a net loss of US$100.7 million. Revenue and loss figures also shifted for the first half.\nSee our latest analysis for Agios Pharmaceuticals.\nThe earnings release appears to have sharpened investor attention on Agios Pharmaceuticals, with a 7.5% 7 day share price return and a 16.1% 90 day share price return standing against...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-in-focus-on-earnings-as-undervalu","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-in-focus-on-earnings-as-undervalu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656587661","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656587661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656587661?lang=en_us&edition=fundamental","pubTime":"2026-08-04 13:30","pubTimestamp":1785821407,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-agios-pharma-agio-novavax-nvax-and-keros-therapeutics-kros-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-agios-pharma-agio-novavax-nvax-and-keros-therapeutics-kros-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XLV","AGIO","KROS","LABU","BK4581","BK4568","BK4139","LU0029874061.USD","BK4585","BK4588","HCSG","XBI","LU0128526141.USD","NVAX","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656299423","title":"U.S. Research Roundup-Abbvie, Amazon, Illumina","url":"https://stock-news.laohu8.com/highlight/detail?id=2656299423","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656299423?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:46","pubTimestamp":1785743176,"startTime":"0","endTime":"0","summary":"CORRECTED-U.S. RESEARCH ROUNDUP-Abbvie, Amazon, IlluminaAug 3 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Amaz","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4400J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FULT","BOH","GDDY","CL","ERX","IYH","BBT","AZYY","FBIZ","CNO","ABBV","AMZN","BKU","AMH","IR","CHD","BRO","FTXO","IYE","CFR","FTAI","GLPI","BEPC","TBBK","AGIO","AMTB","FHN","VDE","CRCL","AGM","XOM","CBNA","GPC","JDOC","ARES","ONLN","WANT","IXJ","CTSH","CVX","GTES","CBNK","EGP","BLCK","CBU","FLG","BOKF","CATY","HUN","FMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656734085","title":"Agios Pharmaceuticals Inc : Leerink Partners Raises Target Price to $73 from $62","url":"https://stock-news.laohu8.com/highlight/detail?id=2656734085","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656734085?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:36","pubTimestamp":1785731803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN43Y0CW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655047369","title":"Agios Pharmaceuticals is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2655047369","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655047369?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:05","pubTimestamp":1785503100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655687703","title":"Agios Pharmaceuticals Inc : Truist Securities Cuts Target Price to $39 from $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2655687703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655687703?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:12","pubTimestamp":1785496329,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X24J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655462358","title":"U.S. Research ROUNDUP-Apple, Amazon, Mastercard","url":"https://stock-news.laohu8.com/highlight/detail?id=2655462358","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655462358?lang=en_us&edition=fundamental","pubTime":"2026-07-31 15:13","pubTimestamp":1785482003,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Apple, Amazon, MastercardJuly 31 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including, Apple, Amazon and M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X0NJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALAB","AWK","ASH","BELFB","BLDR","AVY","AAPL","AXSM","BXMT","BOH","AX","ARXS","ALNY","BMY","BDC","AEP","COWG","MACW.SI","BAX","GNMX","IBAT","VGT","AGIO","BCYC","LABX","POW","AQMS","SMHX","BSX","ALRS","OWL","FDMT","LAZR","BJRI","AMCX","APD","AGCO","AMZN","AR","ALGM","BIOA","AZYY","AMP","BHRB","AJG","BFAM","AXTI","AOS","VT","WHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655040398","title":"Agios Pharmaceuticals price target raised to $55 from $52 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2655040398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655040398?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:40","pubTimestamp":1785429620,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Agios Pharmaceuticals (AGIO) to $55 from $52 and keeps a Buy rating on the shares. The firm updat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-raised-to-55-from-52-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-raised-to-55-from-52-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655808742","title":"Agios Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655808742","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655808742?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:31","pubTimestamp":1785418280,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryAgios Pharmaceuticals IncAGIO.OQreported a quarterly adjusted loss of $1.69 per share for the quarter ended Ju","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL8N43W29C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655879361","title":"Agios Pharmaceuticals Q2 Loss Narrows as Revenue Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2655879361","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655879361?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:05","pubTimestamp":1785409504,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals  reported a Q2 loss Thursday of $1.69 per diluted share, narrowing from a loss of $1.93 a year earlier.Analysts polled by FactSet expected a loss of $1.71.Revenue for the quarter ended June 30 was $44.7 million, up from $12.5 million a year earlier.Analysts surveyed by FactSet expected $26.4 million.Shares of the company were up more than 8% in recent Thursday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655967875","title":"Agios Q2 Revenue Jumps on US Commercial Launch of Aqvesme","url":"https://stock-news.laohu8.com/highlight/detail?id=2655967875","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655967875?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:46","pubTimestamp":1785408392,"startTime":"0","endTime":"0","summary":"Agios Q2 revenue jumps on US commercial launch of AQVESMEOverviewU.S. rare disease drugmaker's Q2 product revenue rose sharplyNet loss for Q2 narrowed year-over-yearGrowth driven by U.S. AQVESME launc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W0I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","BK4585","PBE","BK4505","BK4139","IE00B19Z9P08.USD","BIIB","BK4532","BMED","IE00B894F039.SGD","AGIO","KNSA","LU0889565916.HKD","IE00B19Z9Z06.USD","BK4533","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655071873","title":"Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q2 Net Loss $1.69 a Share, vs. FactSet Est of $1.71 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2655071873","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655071873?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:38","pubTimestamp":1785407937,"startTime":"0","endTime":"0","summary":"Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q2 Net Loss $1.69 a Share, vs. FactSet Est of $1.71 Loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655187395","title":"Agios Pharmaceuticals Q2 EPS $(1.69) Misses $(1.67) Estimate, Sales $44.745M Beat $25.521M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655187395","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655187395?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:31","pubTimestamp":1785407506,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.69) per share which missed the analyst consensus estimate of $(1.67) by 1.2 percent. This is a 12.44 percent increase over losses of $(1.93) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60790950/agios-pharmaceuticals-q2-eps-1-69-misses-1-67-estimate-sales-44-745m-beat-25-521m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.0814},{"period":"3month","weight":-0.2285},{"period":"6month","weight":-0.0337},{"period":"1year","weight":-0.2503},{"period":"ytd","weight":0.1686}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.846154,"avgChangeRate":0.040392},{"month":2,"riseRate":0.692308,"avgChangeRate":0.060535},{"month":3,"riseRate":0.538462,"avgChangeRate":-0.001595},{"month":4,"riseRate":0.538462,"avgChangeRate":-0.007034},{"month":5,"riseRate":0.615385,"avgChangeRate":0.052079},{"month":6,"riseRate":0.692308,"avgChangeRate":0.062482},{"month":7,"riseRate":0.384615,"avgChangeRate":-0.026027},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.029781},{"month":9,"riseRate":0.5,"avgChangeRate":0.038951},{"month":10,"riseRate":0.357143,"avgChangeRate":-0.009662},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033339},{"month":12,"riseRate":0.384615,"avgChangeRate":-0.051358}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agios Pharmaceuticals(AGIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agios Pharmaceuticals,AGIO,Agios Pharmaceuticals股票,Agios Pharmaceuticals股票老虎,Agios Pharmaceuticals股票老虎国际,Agios Pharmaceuticals行情,Agios Pharmaceuticals股票行情,Agios Pharmaceuticals股价,Agios Pharmaceuticals股市,Agios Pharmaceuticals股票价格,Agios Pharmaceuticals股票交易,Agios Pharmaceuticals股票购买,Agios Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agios Pharmaceuticals(AGIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction